0000899243-19-012640.txt : 20190508 0000899243-19-012640.hdr.sgml : 20190508 20190508162712 ACCESSION NUMBER: 0000899243-19-012640 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190506 FILED AS OF DATE: 20190508 DATE AS OF CHANGE: 20190508 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Klompas Neil A CENTRAL INDEX KEY: 0001761857 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38068 FILM NUMBER: 19806993 MAIL ADDRESS: STREET 1: 1385 WEST 8TH AVENUE STREET 2: SUITE 540 CITY: VANCOUVER STATE: A1 ZIP: V6H3V9 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zymeworks Inc. CENTRAL INDEX KEY: 0001403752 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 540-1385 WEST 8TH AVENUE CITY: Vancouver STATE: A1 ZIP: V6H 3V9 BUSINESS PHONE: (604) 678-1388 MAIL ADDRESS: STREET 1: 540-1385 WEST 8TH AVENUE CITY: Vancouver STATE: A1 ZIP: V6H 3V9 FORMER COMPANY: FORMER CONFORMED NAME: Zymeworks Inc DATE OF NAME CHANGE: 20070620 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-05-06 0 0001403752 Zymeworks Inc. ZYME 0001761857 Klompas Neil A C/O ZYMEWORKS INC. 1385 WEST 8TH AVENUE, SUITE 540 VANCOUVER A1 V6H 3V9 BRITISH COLUMBIA, CANADA 0 1 0 0 Chief Financial Officer Common Stock 2019-05-06 4 M 0 6704 2.66 A 7905 D Common Stock 2019-05-06 4 S 0 6704 19.2206 D 1201 D Common Stock 2019-05-06 4 M 0 8380 3.53 A 9581 D Common Stock 2019-05-06 4 S 0 1604 19.2506 D 7977 D Common Stock 700 I Held by spouse Stock Option (Right to Buy) 2.66 2019-05-06 4 M 0 6704 0.00 D 2008-07-01 2019-07-01 Common Shares 6704 0 D Stock Option (Right to Buy) 3.53 2019-05-06 4 M 0 8380 0.00 D 2010-07-01 2019-06-30 Common Shares 8380 0 D The exercise price of the stock option is CAD3.58. The U.S. dollar equivalent of the exercise price is $2.66 using the Bank of Canada exchange rate for May 6, 2019 (CAD1.00 = $0.7432). The shares were sold in multiple transactions and the price reported is a weighted average. The sale prices ranged from $19.07 to $19.48. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The exercise price of the stock option is CAD4.75. The U.S. dollar equivalent of the exercise price is $3.53 using the Bank of Canada exchange rate for May 6, 2019 (CAD1.00 = $0.7432). The shares were sold in multiple transactions and the price reported is a weighted average. The sale prices ranged from $19.13 to $19.365. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date of July 1, 2007, and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date. Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date of July 1, 2009, and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date. /s/ Daniel Dex, Attorney-in-Fact 2019-05-08